JDEPF yields 2.23% · PFE yields 6.13%● Live data
📍 JDEPF pulled ahead of the other in Year 1
Combined, JDEPF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JDEPF + PFE for your $10,000?
JDE Peet's N.V., together with its subsidiaries, provides various coffee and tea products and solutions to serve consumer needs worldwide. The company operates through CPG Europe, CPG LARMEA, CPG APAC, Out-of-Home, and Peet's segments. It offers multi-serve coffee, and single-serve and double-shot coffee capsules; and pads and pods, instant coffee, whole beans, ready-to-drink coffee beverages, various leaf and packaged tea, and professional tea products, as well as rents or sells professional solutions and complementary coffee systems. The company sells its products under the Douwe Egberts, Kenco, Peet's, L'OR, Stumptown, TiOra, Gevalia, Pickwick, PILAO, Intelligentsia, Senseo, Jacobs, Moccona, Super, OldTown, Ofçay, Mighty Leaf Tea, and Tassimo brands through CPG and out-of-home sales channels. It operates 505 coffee stores under the Peet's, Intelligentsia, Stumptown, OldTown, and 12Oz brands in the United States, China, Malaysia, and Italy, as well as through webshops, and third-party e-tailers and e-commerce marketplaces. The company serves various businesses, such as hotels, hospitals, restaurants, cruise liners, and retirement homes, as well as distributors for distribution to the customer; and offices, universities, airports, and sports venues. JDE Peet's N.V. was incorporated in 2018 and is headquartered in Amsterdam, the Netherlands.
Full JDEPF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.